Physician profile
Daniel D Simmons
NPI 1881702371
$349.70
in general payments reported to CMS, 2019-2025
4 companies · $284 in 2025
The $284 reported for 2025 was more than what 82% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.63 · 2021: $21.70 · 2022: $23.91 · 2024: $8.59 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $284 · Food and Beverage: $8.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $283.87 |
| Food and Beverage | $8.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $283.87 | 2025 | |
| Zimmer Biomet Holdings, INC. | $33.33 | 2019-2021 | |
| Zimvie INC. | $23.91 | 2022 | |
| Ultradent Products INC | $8.59 | 2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.